# Galleri Community Research Program

Source: https://onco.cc/trials/galleri-community-research-program/  
OnCo record `galleri-community-research-program` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A small GRAIL pilot that checks whether the medical records of people who had the Galleri test can be collected accurately, ahead of a larger follow-up study.

## Summary

Galleri Community Research Program (NCT06603259) is an observational study sponsored by GRAIL, Inc. Its primary outcome is the quality of data retrieved from participants who have had the Galleri test.

The registry record, read on 29 October 2026, gives its status as unknown (the sponsor last updated it on 19 September 2024), with an estimated 250 participants, a start on 19 August 2024 and primary completion expected in December 2025.

## Fields

- Kind: Trial
- Last checked: 2026-10-29
- Also known as: GRAIL-MA-003
- Registry id: NCT06603259
- Phase: observational
- Setting: People who have already had the Galleri test in the United States, whose medical records are collected to test how well follow-up data can be gathered
- Sponsor: GRAIL, Inc.
- Enrolled: 250

## Sources

- ClinicalTrials.gov NCT06603259: https://clinicaltrials.gov/study/NCT06603259

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [Galleri](https://onco.cc/drugs/galleri/)
- companies: [GRAIL](https://onco.cc/companies/grail/)

---
JSON: https://onco.cc/api/v1/entities/galleri-community-research-program.json